Senior insider sale
President and COO at SYNDAX PHARMACEUTICALS INC — senior position signals high conviction
$2.75M
164.84K shares
What this filing means
METZGER MICHAEL A plans to sell 164.84K shares of SYNDAX PHARMACEUTICALS INC valued at approximately $2.75M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/8/2025ACC: 0001950047-25-006849
Officer· President and COO
Since Feb 2019
164.84K
Shares to sell
$2.75M
Approx. market value
157.31K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/8/2025
157.31KTotal acquired157.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2025 | Exercise of Stock Options Cash | 157.31K | — |
| Total | 157.31K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
7.53K
Market value
$70.0K
7/16/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
157.31K
Market value
$2.68M
9/8/2025
Total
Units
164.84K
Value
$2.75M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/16/2025 | 7.53K | $70.0K | — | Completed |
| Planned — Approximate Date | ||||
9/8/2025 | 157.31K | $2.68M | NASDAQ | Planned |
| Total | 164.84K | $2.75M | ||